Serum sPD-1 and sPD-L1 levels are significantly elevated in Enterobacteriaceae sepsis and dynamically decreased in patients responding to therapy. These findings underscore their potential as valuable prognostic biomarkers for monitoring immune reconstitution and treatment efficacy.
Li et al. (Sat,) studied this question.